OBjeCTive: There is striking paucity in consensus on the terminology, definition, and diagnostic criteria of mycotic aortic aneurysms. This literature study aims to elucidate this scientific omission, discuss its consequences, and present a proposition for reporting items on this disease.
Introduction
A mycotic aortic aneurysm (MAA), synonymously known as infected aortic aneurysm, is an aortic aneurysm due to infection. Mycotic aortic aneurysm most commonly develops through microbial inoculation of the diseased aortic endothelium during bacteremia. 1, 2 Once the microorganism has infected the aortic wall, a fast degradation of the intimal and medial layers may occur, with development of an aneurysm. [3] [4] [5] [6] The causative infective agents are predominantly bacteria but rare cases of fungus have been reported. [7] [8] [9] The term "mycotic aneurysm" is thus a misnomer for infection, and imprecise, while implicating a fungal genesis, which is extremely rare. The term mycotic originates from 1885, when Sir William Osler, in his Gulstonian lectures, described a patient with valve vegetations and 4 aortic aneurysms with morphological fungal resemblance. 10 The term has since stuck, probably because of common usage. Osler was, however, not the first to describe the relationship between infective endocarditis and aneurysm development; Koch in 1851, Tufnell in 1853, and Oggle in 1866 were before him, but not for aneurysms involving the aorta. [11] [12] [13] Many have argued that a more correct term would be infected aortic aneurysm. [14] [15] [16] Throughout the past 130 years, the disease MAA has gone through significant changes; in the days of Osler, most of the aneurysms due to infections were secondary to syphilitic aortitis engaging the adventitia, with aneurysm formation at necrotic focal points due to obliterative endarteritis, 5, 17 or infective endocarditis with septic embolization to the aorta, 5, 14 whereas after the 1940s and the introduction of antibiotics, bacteremia in an aged atherosclerotic aorta is the dominant pathogenetic pathway. 18, 19 A plethora of terms such as "mycotic aneurysm", "primary mycotic aneurysm", "suppurative arteritis", "cryptogenic mycotic aneurysm", "SAP (septic aortic pseudoaneurysm)", and "infected aneurysm" have been used 14, [20] [21] [22] [23] [24] but none with broad acceptance. It is also not uncommon in the literature to mix different infectious conditions involving the aorta, such as graft infection and aorto-enteric fistula together with aortic aneurysms due to infection. [25] [26] [27] There are several problems when studying MAAs such as (a) ill-defined disease, (b) variable terminology indicating fungal genesis, (c) variable or absent diagnostic criteria in the literature, and (d) mixed patient populations with different aortic infections with different natural courses, with various demands on management.
The disease is rare, with an estimated incidence of 0.6% of all aortic aneurysms in Western countries 28, 29 and up to 13% in Taiwan. 23 Hence, most existing studies are underpowered and This article aims to elucidate the absence of definition and classification of MAAs, to discuss the consequences of lack of standardization, and to present a suggestion for reporting items to facilitate comparability between studies.
Methods
A systematic literature search was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement on PubMed and Medline between January 1, 1850 and January 1, 2017. The search terms were mycotic aortic aneurysm and infected aortic aneurysm. Reference lists were also scrutinized to identify additional papers. The ones discussing or introducing new terminology, definitions, diagnostic criteria, and classification were selected for scrutiny. Case series of at least 5 patients were read in full to analyze the diagnostic workup of the study. Case reports were not included. Graft infection and aortoenteric fistulas were excluded. All selected studies were reviewed according to a predefined protocol regarding terminology, definition, diagnostic criteria, and classification of the disease.
Based on previous definitions, current knowledge on the disease, and present clinical needs, a proposition was framed for reporting items to account for when reporting on the disease. Meta-analyses were not possible to perform due to the qualitative nature of the study, neither was risk of bias assessment.
Results
A total of 49 articles were included in the literature analysis, see flowchart in Figure 1 . Whether the disease is increasing is unclear, but the number of publications has doubled per decade on mycotic/infected aneurysms between 1982 and 2012. 30 Table 1 lists different terms being used throughout history with accompanying definitions, diagnostic criteria, or significations attributed to aortic aneurysms caused by infection. The terms infective vasculitis and endovascular infection have mainly been used in the context of intracranial aneurysms due to infection. Since the 1980s, the most prevalent terms have been mycotic and infected aortic aneurysms. The most common definition was not evaluable due to too much diversity.
Terminology and definitions

Pathophysiology and subclassifications
It has been recognized that MAAs might arise from different causes, see Table 2 . [1] [2] [3] [4] [5] [6] 9 The table is a modified version of Wilson et al 36 from 1978 . In addition to the Wilson classification, one more group has been added, ie, HIV-related aneurysms. These aneurysms are seen in young patients with advance-stage HIV infection, median age of 30 years with multiple aneurysms throughout the arterial system, and so far they have only been reported from the province of KwaZulu-Natal in the Republic of South Africa. The precise pathogenesis is unclear but there is to date no evidence of direct viral action leading to arterial wall destruction. 42 However, viral infection cannot be excluded as the pathogenetic pathway.
Diagnosis
Different criteria for aneurysms due to infection have been in use (Table 1 ). In the past 15 years, the diagnosis MAA has been based on a various combination of the following 4 criteria: (1) clinical presentation (pain, fever, concomitant infection, elderly patient with cardiovascular disease, and/or immunosuppressive state); (2) laboratory findings (raised inflammatory parameters including C-reactive protein [CRP], leukocytosis, and positive culture); (3) radiological findings on computed tomography (CT) or magnetic resonance imaging (saccular, eccentric, or multilobular aneurysm, periaortic mass, periaortic gas, and rapid aortic expansion) ( Figure  2 ); and (4) intraoperative findings. One of the criteria is solely not sufficient for the diagnosis. However, there is no algorithm for making the diagnosis. Whether a positive blood culture is a prerequisite for the diagnosis or not is a point of disagreement. 24, [55] [56] [57] 61 Argument for positive culture being requisite, either in blood or tissue, is that it is the only way to certify an infectious pathophysiologic mechanism. Arguments against a positive culture being requisite are that it is known that these aneurysms yield a positive blood or tissue culture in only approximately 50% to 75% of the cases, even if harvested from the aneurysm sac with evident infection intraoperatively. This could be explained by difficulties in obtaining anaerobic cultures or initial broad-spectrum antibiotic therapy. 43, 62, 63 Also, if treated endovascularly, a tissue culture may not be obtained. 24 Older studies have demonstrated that routine culture of abdominal aortic aneurysm wall during surgery of clinically noninfected patients may be positive in 14% to 37%, which adds further complexity to this issue. [64] [65] [66] The value of positron emission tomography (PET) and granulocyte scintigraphy has not been evaluated properly but could probably aid in diagnostics in uncertain cases.
Most authors make clear distinction between an aneurysm due to infection and aorto-enteric fistulas and graft infections.
Proposition for reporting items
To facilitate comparisons between studies on MAA the following 10 essentials would preferably be accounted for: 
Discussion
What is unclearly said, is unclearly thought
Esaias Tegnér, 1782-1846, member of the Swedish academy and professor in Greek.
Mycotic aortic aneurysms are extremely rare, making the disease difficult to study and statistical analyses problematic. Meanwhile, its management is very demanding and carries high mortality. 28, 29, 67 It is obvious that the terminology, definition, and diagnostic criteria of MAA are confusing. This confusion complicates comparisons between case series when this is necessary because collecting cases of MAA is a major undertaking and evidence-based treatment is lacking. An explicit definition with coherent terminology and It is important to distinguish MAAs from secondary aortic infections, such as graft infections, secondary aorto-enteric fistulas, and also inflammatory aneurysms, IgG4-related inflammatory aneurysms, and penetrating aortic ulcers because of differences in natural history and demand on management. 2, 8, 28, 29, 68, 69 A consensus document would be welcome as both the Society for Vascular Surgery (SVS) and the European Society for Vascular Surgery (ESVS) lack guidelines in treatment of MAAs. There is also a demand on evidence-based treatment guidelines because there are indications that the incidence of MAA is increasing. 30, 61 However, there may be many challenges defining MAAs, for example, the morphological characteristics of the aneurysm will probably matter. Most MAAs are saccular, but what is a saccular aneurysm? There is no distinct definition of saccular aneurysm either; should the diameter matter, and how should it be measured?
The same work remains for graft infections and aortoenteric fistulas. The work by the MAGIC group is an important, encouraging step in the right direction, where a diagnostic algorithm was constructed for aortic graft infection by a multidisciplinary panel of experts. 70 Until similar work is done for MAAs, this paper might stimulate the classification process, making comparisons between studies more standardized.
To date, there is not one meta-analysis on this disease, and the explanation is part the rarity of the disease, and part that the reporting is too disparate making comprehensible meta-analysis impossible. The purpose of presenting a suggestion for reporting items is to facilitate comparisons between studies in the future.
However, a consensus document to settle these issues is warranted. Such document would desirably also contain reporting standards, as the ones proposed in this article were a mere synthesis of obvious divergent reporting, or lack thereof in the literature. Until then, the diagnostic syndromic algorithms used by the teams in Taipei, Taiwan, and Uppsala, Sweden, will have to suffice, where a combination of clinical, laboratory and imaging findings compose the basis for the diagnostic workup. 8, 29 
Conclusions
This article puts an emphasis on the need to standardize definition, terminology, and diagnostic criteria for MAAs and proposes reporting items enhancing comparability between studies.
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